August 24 (SeeNews) - Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said on Wednesday its net profit soared to 18.6 million marka ($9.46 million/9.51 million euro) in the first half of 2022 from 1.6 million marka booked in the like period of last year.
Operating income grew 14.6% on the year, reaching 55.1 million marka in the January-June period, whereas operating costs rose 8% to 54.5 million marka, Bosnalijek said in a filing to the Sarajevo Stock Exchange (SASE).
Bosnalijek's first-half financial income jumped to 23.8 million marka, from 6.7 million marka reported for the first six months of 2021. Financial costs went down 15.4% year-on-year to 2.2 million marka in the period under review.
The company's shares closed 4.62% lower at 31.24 marka on the SASE on Tuesday. They did not trade by 12:13 CET.
Bosnalijek is the largest pharmaceuticals company in Bosnia and Herzegovina.
(1 euro = 1.95583 marka)